- Filed
- Jun 25, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Jun 17, 2024 | 45.79M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 40.83M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 39.94M sh |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$126.95K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$1.25M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $71.57K |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $100.32K |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | −$8.23M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | −$7.14M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $8.89M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $8.03M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $9.05M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $8.21M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $573.17K |
| Current Assets | Q1 2024 · Dec 31, 2023 | $806.62K |
| Total Assets | Q1 2024 · Mar 31, 2024 | $820.12K |
| Total Assets | Q1 2024 · Dec 31, 2023 | $1.07M |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | −$0.01 |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$0.07 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | −$0.01 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$0.07 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $349.73K |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $426.55K |
| Net Income | Q1 2024 · Mar 31, 2024 | −$423.49K |
| Net Income | Q1 2024 · Mar 31, 2023 | −$2.95M |
| Operating Income | Q1 2024 · Mar 31, 2024 | $512.5K |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$2.68M |
| Gross Profit | Q1 2024 · Mar 31, 2024 | $282.28K |
| Gross Profit | Q1 2024 · Mar 31, 2023 | $191.62K |
| Cost Of Revenue | Q1 2024 · Mar 31, 2024 | $62.18K |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $80.02K |
| Revenue | Q1 2024 · Mar 31, 2024 | $344.47K |
| Revenue | Q1 2024 · Mar 31, 2023 | $271.64K |